ClinicalTrials.gg
RecruitingNCT07011628TABSUpdated Sep 21, 2026

Transition to Ambulatory Bariatric Surgery (TABS) Trial

An interventional study of Same Day Discharge in Obesity and Obesity-related Medical Conditions and Bariatric Surgery, sponsored by Vanderbilt University Medical Center. Recruiting at 1 site in United States. Open to participants aged 25 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-09-21.

Sponsored by Vanderbilt University Medical Center · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
25 Years to 55 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 40 studies in Obesity by Vanderbilt University Medical Center — 7 open to participants now, 12 under way, 1 of them phase 3. Obesity · Vanderbilt University Medical Center.

Planned enrollment
3rd of 33
200 · median 29
Started
2026
with 3 others
No phase
9 of 40
2 open now
Primary completion
2027-10
later than 6 of 11 live
Registered
36th of 40
by date

Among the 40 studies in Obesity by Vanderbilt University Medical Center, this one is the 3rd largest by planned enrollment of the 33 interventional ones that give a count, is one of 4 that started in 2026, is one of 9 with no phase, reaches primary completion later than 6 of the 11 other live ones, and was the 36th registered.

Obesity

11,564 studies on the registry are indexed under Obesity; 2,063 are open to participants now.

Browse Obesity studies →

Open to participants now

7 of the 40 studies in Obesity by Vanderbilt University Medical Center are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 7 open studies →

Where they have run

Who these studies take

Of the 1,352 Obesity studies recruiting now, 382 (28%) set no upper age limit and 867 (64%) stop at 75 or younger; 169 take children under 18; 491 take healthy volunteers.

This study: 25 Years to 55 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 40 studies in Obesity by Vanderbilt University Medical Center, or all of them as a file.
02

Study summary

This study will compare same day discharge and at least one night stay in the hospital after bariatric surgery. Patients undergoing bariatric surgery will be randomized (i.e. have an equal chance of either plan) to either group. The study's primary outcome is the frequency patients in the study require a visit to the emergency room within 7 days of their surgery.

Read the detailed description

This pragmatic, parallel, randomized, open-label trial aims to determine the safety and feasibility of same day discharge (SDD) for bariatric surgery including sleeve gastrectomy and gastric bypass. Investigators will investigate the frequency of 7-day emergency department visits with SDD after bariatric surgery (Aim 1). In addition, the investigators will compare total 30-day charges between participants who undergo same day discharge versus those receive post-operative hospital admission (Aim 2).

03

Conditions studied

  • Obesity and Obesity-related Medical Conditions
  • Bariatric Surgery

Browse trials for

Keywords

  • ambulatory surgery
  • same day discharge
  • gastric bypass
  • sleeve gastrectomy
04

Who can participate

Ages eligible
25 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • ≤ 60 kg/m2
  • Primary Sleeve gastrectomy or Gastric Bypass,
  • Undergoing bariatric surgery at sponsor site

Exclusion criteria

Exclusion Criteria:

  • Type 1 Diabetes
  • Myocardial Infarction
  • Unstable Angina or Heart Failure
  • Prior Stroke
  • Solid organ transplantation
  • Systemic prior 28 days
  • Severe Obstructive Sleep Apnea
  • Uncontrolled Hypertension (Systolic > 150, Diastolic > 90)
  • Untreated Hyperthyroidism
  • Chronic Kidney Disease (EGFR \< 60)
  • Current anticoagulant use,
  • Poorly controlled Type 2 diabetes ( in last 3 months > 8.5%)
  • Chronic opioid use
  • Insulin dependence.
  • Need for extended venous thromboembolic event prophylaxis,
  • > 1 lifetime bariatric surgery (revisional or conversion bariatric surgery)
  • Patient lives > 130 miles from the hospital.
  • Tobacco use in last 12 months
  • Desire to become pregnant or active pregnancy
  • Prisoners
  • Unable or unwilling to follow-up
  • Unable to understand or provide consent
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

HbA1c

A blood test of average blood sugar over the past two to three months, given as a percentage or in mmol/mol. 6.5% (48 mmol/mol) or more is the usual threshold for diabetes, normally confirmed by a second test.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (estimated)

Study arms

  • Active comparator
    Same Day Discharge

    Patients in the same day discharge will be discharged from the hospital following surgery without an overnight stay in the hospital.

    Other: Same Day Discharge

  • No intervention
    Standard of care - Hospital Admission

    Patients in the standard of care arm will be admitted to the hospital for at least one overnight stay in the hospital.

Interventions

  • OtherSame Day Discharge

    Patients in the same day discharge arm will be discharged from the hospital within 6 hours of arriving to the recovery unit and without an overnight stay in the hospital.

06

What researchers measure

Primary outcomes

  1. Emergency Department Visits

    Number of emergency room visits after surgery

    Time frame: baseline to seven days

Secondary outcomes

  1. Readmissions to the hospital

    Study personnel will investigate the incidence of readmissions to the hospital in the post-surgical period.

    Time frame: baseline to 30 days

  2. The number of operations or procedures

    Study personnel will compare the frequency of reoperations and procedural interventions after surgery

    Time frame: baseline to 30 days

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All participant-level data will be preserved and shared. Shared data will be deidentified prior to sharing. Clinicaltrials.gov will document recruitment progress and final results. Study protocols will be shared with publications as supplementary data and made available upon request. All participant consent document will be collected and stored electronically utilizing the REDCap study data repository. The REDCap data warehouse will also contain the study data dictionary. Study protocols have also been published on the ClinicalTrials.gov and any protocol amendments will be reflected on the ClinicalTrials.gov study page. The investigators will utilize the Research Electronic Data Capture (REDCap) data warehouse maintained locally at Vanderbilt for all data collection. Upon study completion and prior to closing the REDCap data warehouse for this study, the investigators will archive all data after removing patient identifiers in the Open Science Framework data repository.

Supporting information: Study protocol, Statistical analysis plan, Informed consent form

Time frame: Per institutional policy, data will be maintained in the local REDCap data repository for 6 years after closure of the study. Following this period, data will be deidentified and uploaded to the OSF repository, which has funding for at least 50 years of data storage.

Access criteria: Data will be made available upon request after completion of appropriate institutional review board approval and data use agreement obtainment.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Oct 2026; primary completion for Oct 2027, 12 months later.

Of 3,697 non-industry interventional studies with no phase under Obesity, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 43. This study's planned 12 months is below that.

Counting every sponsor, half of 3,861 studies reached it within 22 months; a quarter within 9 and three quarters within 42.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 5, 2025
First posted
Jun 9, 2025
StartEst.
Oct 1, 2026
Primary completionEst.
Oct 1, 2027
CompletionEst.
May 1, 2028
Last update
Sep 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 21, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07011628
Responsible party
Jason Samuels (Principal Investigator, Vanderbilt University Medical Center) — Principal investigator
First posted
Jun 9, 2025
Start date
Oct 1, 2026 (estimated)
Primary completion
Oct 1, 2027 (estimated)
Completion
May 1, 2028 (estimated)
Last update
Sep 21, 2026

Study contacts

Jason Samuels
Contact
jason.m.samuels@vumc.org
(615) 322 - 4504 ext. 24504

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion